Title

Lasmiditan for the Treatment of Migraines With or Without Aura in Adults.

Document Type

Article

Publication Title

Psychopharmacology Bulletin

ISSN

2472-2448

Volume

50

Issue

4 Suppl 1

First Page

163

Last Page

188

Publication Date

10-15-2020

Abstract

Migraines are a common form of primary headache, affecting women more than men (17.4% and 5.7% of US population, respectively, a total of 12%) that carry significant morbidity and disability, as well as a hefty healthcare price tag. They are most prevalent in women of reproductive ages and are estimated to be the 6th disease in order of causing global burden. They are estimated to cause 45.1 million years lived with disability, or 2.9% of global years lost to disability. Migraine treatment divides into acute, abortive treatment for relief of an ongoing migraine attack, and prophylactic therapy to reduce the occurrence of migraines, specifically for patients suffering from chronic and frequent episodic migraines. Traditional abortive treatment usually begins with NSAID and non-specific analgesics that are effective in curbing mild to moderate attacks. 5HT

Share

COinS